日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors.

硼替佐米和氯法拉滨联合治疗难治性肿瘤成人患者的 I 期试验。

Ahmed Jibran, DeSouza Andre, Kummar Shivaani, Rubinstein Lawrence, O'Sullivan-Coyne Geraldine, Govindharajulu Jeevan, Herrick William, Ferry-Galow Kate, Li Li, Wilsker Deborah F, Hogu Murielle, Piekarz Richard, Meehan Robert, Salkeni Mohamad Adham, Shin Sarah, Miller Brandon, Zlott Jennifer, Juwara Lamin, Gray Karen, Kuhlmann Laura, Srivastava Apurva, Parchment Ralph E, Doroshow James H, Takebe Naoko, Chen Alice P

A Phase I Study of Nilotinib in Combination with Paclitaxel in Patients with Advanced Solid Tumors

尼洛替尼联合紫杉醇治疗晚期实体瘤患者的I期研究

Shin, Sarah J; O'Sullivan Coyne, Geraldine; Kummar, Shivaani; Miller, Sarah B; Johnson, Barry C; Anderson, Larry; Rubinstein, Larry; Miller, Brandon; Wilsker, Deborah F; Ferry-Galow, Katherine V; Piekarz, Richard; Zlott, Jennifer; Hogu, Murielle; Juwara, Lamin; Krushkal, Julia; Konaté, Mariam; Palmisano, Alida; Zhao, Yingdong; Collins, Jerry; Parchment, Ralph E; Doroshow, James H; Chen, Alice P

Safety and Tolerability of Berzosertib, an Ataxia-Telangiectasia-Related Inhibitor, and Veliparib, an Oral Poly (ADP-ribose) Polymerase Inhibitor, in Combination With Cisplatin in Patients With Refractory Solid Tumors

Berzosertib(一种共济失调毛细血管扩张症相关抑制剂)和 Veliparib(一种口服聚(ADP-核糖)聚合酶抑制剂)联合顺铂治疗难治性实体瘤患者的安全性和耐受性

O'Sullivan Coyne, Geraldine; Do, Khanh T; Kummar, Shivaani; Piha-Paul, Sarina; Rubinstein, Lawrence; Kinders, Robert; Parchment, Ralph E; Wilsker, Deborah; Ferry-Galow, Katherine; Miller, Brandon; Takebe, Naoko; Juwara, Lamin; Ong, Mary Jane; Bruns, Ashley; Hogu, Murielle; Naqash, Abdul Rafeh; Mittra, Arjun; Voth, Andrea Regier; Doroshow, James H; Chen, Alice P

Phase 1 studies of the indenoisoquinolines LMP776 and LMP744 in patients with solid tumors and lymphomas

针对实体瘤和淋巴瘤患者的茚并异喹啉类化合物LMP776和LMP744的I期研究

O'Sullivan Coyne, Geraldine; Kummar, Shivaani; Rubinstein, Larry V; Wilsker, Deborah; Moore, Nancy; Hogu, Murielle; Piekarz, Richard; Covey, Joe; Beumer, Jan H; Ferry-Galow, Katherine V; Villaruz, Liza C; Hollingshead, Melinda G; Holleran, Julianne L; Deppas, Joshua J; Pommier, Yves; Ko, Brian; Johnson, Barry C; Parchhment, Ralph E; Ivy, Percy; Doroshow, James H; Chen, Alice P

Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors

药物治疗后 HDAC 和 SIRT 基因表达变化与癌细胞系对激酶抑制剂敏感性的关联

Krushkal, Julia; Zhao, Yingdong; Roney, Kyle; Zhu, Weimin; Brooks, Alan; Wilsker, Deborah; Parchment, Ralph E; McShane, Lisa M; Doroshow, James H

Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors

PARP抑制剂他拉唑帕尼(MDV3800,BMN 673)在BRCA突变晚期实体瘤患者中的药效学作用

Mittra, Arjun; Coyne, Geraldine H O' Sullivan; Zlott, Jennifer; Kummar, Shivaani; Meehan, Robert; Rubinstein, Lawrence; Juwara, Lamin; Wilsker, Deborah; Ji, Jiuping; Miller, Brandon; Navas, Tony; Ferry-Galow, Katherine V; Voth, Andrea Regier; Chang, Ting-Chia; Jiwani, Shahanawaz; Parchment, Ralph E; Doroshow, James H; Chen, Alice P

Atezolizumab for Advanced Alveolar Soft Part Sarcoma

阿特珠单抗治疗晚期肺泡软组织肉瘤

Chen, Alice P; Sharon, Elad; O'Sullivan-Coyne, Geraldine; Moore, Nancy; Foster, Jared C; Hu, James S; Van Tine, Brian A; Conley, Anthony P; Read, William L; Riedel, Richard F; Burgess, Melissa A; Glod, John; Davis, Elizabeth J; Merriam, Priscilla; Naqash, Abdul R; Fino, Kristin K; Miller, Brandon L; Wilsker, Deborah F; Begum, Asma; Ferry-Galow, Katherine V; Deshpande, Hari A; Schwartz, Gary K; Ladle, Brian H; Okuno, Scott H; Beck, Jill C; Chen, James L; Takebe, Naoko; Fogli, Laura K; Rosenberger, Christina L; Parchment, Ralph E; Doroshow, James H

PARP Inhibitor Applicability: Detailed Assays for Homologous Recombination Repair Pathway Components

PARP抑制剂适用性:同源重组修复通路组分的详细检测

O'Sullivan Coyne, Geraldine; Karlovich, Chris; Wilsker, Deborah; Voth, Andrea Regier; Parchment, Ralph E; Chen, Alice P; Doroshow, James H

Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors

一项针对晚期实体瘤患者的每日一次 Wee1 抑制剂 Adavosertib (AZD1775) 的 I 期试验的安全性、抗肿瘤活性和生物标志物分析

Takebe, Naoko; Naqash, Abdul Rafeh; O'Sullivan Coyne, Geraldine; Kummar, Shivaani; Do, Khanh; Bruns, Ashley; Juwara, Lamin; Zlott, Jennifer; Rubinstein, Larry; Piekarz, Richard; Sharon, Elad; Streicher, Howard; Mittra, Arjun; Miller, Sarah B; Ji, Jiuping; Wilsker, Deborah; Kinders, Robert J; Parchment, Ralph E; Chen, Li; Chang, Ting-Chia; Das, Biswajit; Mugundu, Ganesh; Doroshow, James H; Chen, Alice P

Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas

TRC102(盐酸甲氧基胺)联合替莫唑胺治疗复发性实体瘤和淋巴瘤患者的I期临床试验

Coyne, Geraldine O'Sullivan; Kummar, Shivaani; Meehan, Robert S; Do, Khanh; Collins, Jerry M; Anderson, Larry; Ishii, Kazusa; Takebe, Naoko; Zlott, Jennifer; Juwara, Lamin; Piekarz, Richard; Streicher, Howard; Sharon, Elad; Rubinstein, Larry; Voth, Andrea Regier; Lozier, Jay; Dull, Angie B; Wilsker, Deborah; Hinoue, Toshinori; Laird, Peter W; Ferry-Galow, Katherine V; Kinders, Robert J; Parchment, Ralph E; Doroshow, James H; Chen, Alice P